A key change to the Drugs and Cosmetics Act that it proposes will allow pharma companies to simply pay a fine for manufacturing substandard drugs and avoid jail time, warn activists.
Subscribe to read this story
We publish over 500 original, detailed stories every year on startups, corporates, stock markets and economic current affairs.
Limited time offer $125 $99 for 1 year
India will need to bring about massive changes if it wants to take advantage of the US’s solidifying stance against tech investments in China.
With the DPI export, India gets to extend its soft power and create new opportunities for companies. But what if this technology, already marred with safety and privacy issues, falls into the wrong hands?
The disqualification of the wrestler—denying her a shot at an Olympic gold medal—for being a mere 100 g over the limit, begs the question: do the rules around weight need a rethink?